Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection

PURPOSE: The Coronavirus disease 2019 (COVID-19) pandemic is one of the most devastating global problems. Regarding the lack of disease-specific treatments, repurposing drug therapy is currently considered a promising therapeutic approach in pandemic situations. Recently, the combination therapy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Akbarzadeh-Khiavi, Mostafa, Torabi, Mitra, Rahbarnia, Leila, Safary, Azam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666469/
https://www.ncbi.nlm.nih.gov/pubmed/34902115
http://dx.doi.org/10.1007/s15010-021-01730-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666469/
https://www.ncbi.nlm.nih.gov/pubmed/34902115
http://dx.doi.org/10.1007/s15010-021-01730-6

Ejemplares similares